Butorphanol: Effects of a Prototypical Agonist-Antagonist Analgesic on κ-Opioid Receptors
The opioid analgesic, butorphanol (17-cyclobutylmethyl-3,14-dihydroxymorphinan) tartrate is a prototypical agonist-antagonist opioid analgesic agent whose potential for abuse has been the cause of litigation in the United States. With a published affinity for opioid receptors in vitro of 1:4:25 (µ:δ...
Main Authors: | Stephen Commiskey, Lir-Wan Fan, Ing K. Ho, Rob W. Rockhold |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2005-01-01
|
Series: | Journal of Pharmacological Sciences |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1347861319321899 |
Similar Items
-
Opiate, Opioid analgesics and antagonists
by: Milton Faccione, et al.
Published: (2005-02-01) -
Sedative and analgesic effects of detomidine or detomidine and butorphanol in the donkey
by: Joubert, Kenneth Edward
Published: (2013) -
The sedative and analgesic effects of detomidine-butorphanol and detomidine alone in donkeys
by: K.E. Joubert, et al.
Published: (1999-07-01) -
Studies of Opioid Agonists and Antagonists on Cardiac Function
by: CHI-FENG HUNG, et al.
Published: (1999) -
The mechanisms of ultra-low dose opioid agonist-antagonist
by: Chih-Shung Wong, MD, PhD.
Published: (2011-10-01)